An evaluation of the efficacy and safety of tegaserod 6 mg bid given orally to Chinese patients with chronic constipation

Trial Profile

An evaluation of the efficacy and safety of tegaserod 6 mg bid given orally to Chinese patients with chronic constipation

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Tegaserod (Primary)
  • Indications Constipation
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Feb 2007 Results have been reported.
    • 15 Feb 2007 Status changed from recruiting to completed.
    • 19 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top